True Cell Type,Predicted Main Cell Type,Predicted Sub Cell Types,Possible Mixed Cell Types,Marker Number,Marker List,Iterations,Model,Provider,Tissue,Species,Additional Info,Conversation History
"cd8-positive, alpha-beta t cell",Cytotoxic Lymphocyte,"Activated Natural Killer (NK) Cells or NK-like T cells (e.g., NKT-like, Gamma-delta T cells with NK features), Cytotoxic CD8+ T Lymphocytes (CTLs), Gamma-Delta T Cells with Cytotoxic Potential","Activated NK Cells or a hybrid population of NK-like T cells (e.g., NKT-like cells or cytotoxic gamma-delta T cells) with a strong NK cell signature",50,"KLRC2, XCL2, LINC02446, CRTAM, KLRK1, KLRC4, KLRD1, XCL1, GZMH, CD160, CD8B, NKG7, GZMA, GZMB, GZMK, CD8A, TRGC2, SLA2, TIGIT, TNFRSF9, GPR18, CCL4, PRF1, ATP8B4, APBA2, CCL4L2, DUSP4, CTSW, TMIGD2, TRGC1, CCL5, ABI3, IL21R, IFNG, CD7, CLIC3, ENTPD1, LDLRAD4, PTPN22, HOPX, GZMM, CST7, PARD6G, ZEB2, SH2D1A, LAYN, LAG3, PRKCH, AOAH, IKZF2",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a detailed analysis to identify the cell type based on the provided marker list: **Step 1. List the Key Functional Markers:** This list is rich in genes associated with cytotoxic function and immune regulation. * **Cytotoxicity & Granule-associated Proteins:** * **GZMH, GZMA, GZMB, GZMK:** Granzymes are serine proteases found in the granules of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells. They induce apoptosis in target cells. GZMH and GZMB are particularly strong indicators of cytotoxicity. * **PRF1 (Perforin 1):** A pore-forming protein crucial for the delivery of granzymes into target cells, a hallmark of cytotoxic lymphocytes. * **NKG7:** A transmembrane protein found in the granules of NK cells and CTLs, involved in granule exocytosis. * **CST7 (Cystatin F):** A cysteine protease inhibitor, often co-expressed with granzymes in cytotoxic lymphocytes. * **Chemokines & Chemokine Receptors:** * **XCL2, XCL1:** Lymphotactin (XCL1/2) are C-motif chemokines primarily expressed by NK cells and cytotoxic T cells, attracting other immune cells. * **CCL4, CCL4L2, CCL5:** Chemokines involved in recruiting various immune cells, including NK cells, T cells, and monocytes, to sites of inflammation. * **GPR18:** A G protein-coupled receptor, sometimes associated with immune cell trafficking. * **Cytokines & Cytokine Receptors:** * **IFNG (Interferon-gamma):** A potent pro-inflammatory cytokine produced by NK cells and T cells, critical for antiviral and antitumor immunity. * **IL21R:** Receptor for Interleukin-21, which plays a role in the differentiation and function of NK cells and T cells. * **TNFRSF9 (4-1BB):** A co-stimulatory receptor expressed on activated T cells and NK cells, enhancing their survival and function. * **Immune Checkpoints & Regulatory Molecules:** * **TIGIT (T cell immunoreceptor with Ig and ITIM domains):** An inhibitory receptor expressed on NK cells and T cells, involved in immune suppression. * **LAG3 (Lymphocyte-activation gene 3):** An inhibitory receptor expressed on activated T cells and NK cells, contributing to immune exhaustion. * **PTPN22:** A lymphoid-specific phosphatase, involved in regulating T cell activation. * **SH2D1A (SAP):** An adaptor protein critical for NK cell and T cell activation and cytotoxicity, particularly in NKT cells. * **Other Functional Markers:** * **DUSP4:** A dual-specificity phosphatase, involved in regulating MAPK signaling pathways in immune cells. * **ABI3:** An adaptor protein involved in actin cytoskeleton organization and immune cell signaling. * **ENTPD1 (CD39):** An ectonucleotidase, involved in regulating purinergic signaling and immune suppression. **Step 2. List the Key Cell Type Markers:** This list strongly points towards cytotoxic lymphocytes, with a clear emphasis on NK cells and cytotoxic T cells. * **Natural Killer (NK) Cell Markers:** * **KLRC2 (NKG2C), KLRK1 (NKG2D), KLRC4 (NKG2F), KLRD1 (CD94):** These are C-type lectin-like receptors, characteristic of NK cells. NKG2C and NKG2D are activating receptors, while CD94 forms a complex with NKG2A (not listed but often co-expressed) which is inhibitory. The presence of multiple KLR genes is a very strong indicator of NK cells. * **CD160:** A glycosylphosphatidylinositol-anchored receptor expressed on NK cells and cytotoxic T cells, involved in cytotoxicity. * **CRTAM (Class I-restricted T cell-associated molecule):** Expressed on NK cells and some T cells, involved in cell-cell adhesion and activation. * **Cytotoxic T Lymphocyte (CTL) Markers:** * **CD8B, CD8A:** Components of the CD8 co-receptor, defining cytotoxic T lymphocytes (CTLs). * **TRGC2, TRGC1:** T cell receptor gamma chain genes, indicating gamma-delta T cells. The presence of both TRGC1 and TRGC2 suggests a population of gamma-delta T cells, which often exhibit cytotoxic functions similar to NK cells and alpha-beta CTLs. * **General Lymphocyte Markers:** * **CD7:** A pan-T cell marker, also expressed on NK cells and some myeloid cells. * **IKZF2 (Helios):** A transcription factor expressed in regulatory T cells and some activated effector T cells. Its presence here, alongside strong cytotoxic markers, might indicate activated effector T cells or a subset of NK cells. **Step 3. Cross-reference Known Databases:** A quick search in scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker) for these markers confirms their strong association with: * **NK cells:** KLRC2, KLRK1, KLRC4, KLRD1, NKG7, GZMH, GZMB, PRF1, XCL1, XCL2, CD160, CRTAM, IFNG, CCL4, CCL5. * **Cytotoxic T cells (CD8+ T cells):** CD8A, CD8B, GZMA, GZMB, GZMH, PRF1, NKG7, IFNG, CCL4, CCL5, TIGIT, LAG3, TNFRSF9. * **Gamma-delta T cells:** TRGC1, TRGC2, GZMA, GZMB, PRF1, IFNG, often share features with NK cells. The co-expression of NK-specific C-type lectin receptors (KLRCs, KLRK1, KLRD1) with CD8A/B and gamma-delta TCR components is particularly informative. **Step 4. Determine the Most Probable General Cell Type:** The overwhelming presence of genes associated with cytotoxicity (granzymes, perforin, NKG7), NK cell receptors (KLRCs, KLRK1, KLRD1), and T cell co-receptors (CD8A/B, TRGC1/2) strongly points to a **Cytotoxic Lymphocyte** population. **Step 5. Identify the Top 3 Most Probable Sub Cell Types:** 1. **Most Likely: Activated Natural Killer (NK) Cells or NK-like T cells (e.g., NKT-like, Gamma-delta T cells with NK features):** * **Reasoning:** The presence of multiple NK-specific C-type lectin receptors (KLRC2, KLRK1, KLRC4, KLRD1) is extremely strong evidence for an NK cell component. The high expression of XCL1/2, GZMH, GZMB, PRF1, NKG7, and IFNG further supports an activated, cytotoxic NK cell phenotype. The co-expression of CD8A/B and TRGC1/2, along with NK markers, suggests a population that might bridge NK and T cell characteristics, such as NKT cells or gamma-delta T cells that have adopted an NK-like cytotoxic profile. In the large intestine, these populations are particularly relevant for immune surveillance. 2. **Second Most Likely: Cytotoxic CD8+ T Lymphocytes (CTLs):** * **Reasoning:** The clear expression of CD8A and CD8B, along with a robust cytotoxic machinery (GZMA, GZMB, GZMH, PRF1, NKG7, IFNG), strongly indicates the presence of cytotoxic CD8+ T cells. Markers like TIGIT, LAG3, and TNFRSF9 are also commonly found on activated or exhausted CTLs. While NK markers are prominent, a significant proportion of these cells could be conventional CD8+ T cells. 3. **Third Most Likely: Gamma-Delta T Cells with Cytotoxic Potential:** * **Reasoning:** The presence of TRGC1 and TRGC2 is a direct indicator of gamma-delta T cells. These cells are known to reside in mucosal tissues like the large intestine and often exhibit potent cytotoxic functions, sharing many effector molecules with NK cells and alpha-beta CTLs (granzymes, perforin, IFNG). Their co-expression with NK receptors (KLRCs, KLRK1) is also reported, suggesting an NK-like phenotype in some gamma-delta T cell subsets. **Most Likely Subtype:** Given the prominence and diversity of NK-specific C-type lectin receptors (KLRC2, KLRK1, KLRC4, KLRD1) alongside the strong cytotoxic effector molecules and the presence of CD8 and gamma-delta TCR components, the most likely specific subtype is **Activated NK Cells or a hybrid population of NK-like T cells (e.g., NKT-like cells or cytotoxic gamma-delta T cells) with a strong NK cell signature.** The large intestine is known to harbor diverse innate lymphoid cells and unconventional T cell subsets that exhibit NK-like functions. The combination of markers here points to a highly active, innate-like cytotoxic lymphocyte. **Step 6. Provide a Concise Summary of Your Analysis:** This cell cluster is identified as a **Cytotoxic Lymphocyte** population. The marker profile is dominated by genes associated with cytotoxicity (GZMA, GZMB, GZMH, PRF1, NKG7, IFNG) and a strong presence of **Natural Killer (NK) cell-specific receptors** (KLRC2, KLRK1, KLRC4, KLRD1). Additionally, markers for cytotoxic CD8+ T cells (CD8A, CD8B) and gamma-delta T cells (TRGC1, TRGC2) are expressed, suggesting a potential overlap or a heterogeneous population. The most probable specific cell type is **Activated NK Cells or NK-like T cells (e.g., NKT-like or cytotoxic gamma-delta T cells)**, given the prominent NK receptor expression combined with the robust cytotoxic machinery. This population likely plays a critical role in immune surveillance and host defense within the large intestine. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Cytotoxic Lymphocyte"", ""sub_cell_types"": [ ""Activated Natural Killer (NK) Cells or NK-like T cells (e.g., NKT-like, Gamma-delta T cells with NK features)"", ""Cytotoxic CD8+ T Lymphocytes (CTLs)"", ""Gamma-Delta T Cells with Cytotoxic Potential"" ], ""possible_mixed_cell_types"": [ ""Activated NK Cells or a hybrid population of NK-like T cells (e.g., NKT-like cells or cytotoxic gamma-delta T cells) with a strong NK cell signature"" ] } ```"
intestinal crypt stem cell,Intestinal Stem Cells (ISCs),"LGR5+ Crypt Base Columnar (CBC) Stem Cells, Secretory-biased Intestinal Stem Cells, Quiescent/Reserve Intestinal Stem Cells",,50,"AL031284.1, AC012085.1, IGFBPL1, HMGN2P6, CHCHD2P9, PPIAP40, LGR5, RPL7P54, AC010132.3, EIF5AP4, AC008694.2, COX5AP2, TDGF1, ASCL2, AC092670.1, NPM1P6, PPIAP11, AC090498.1, RPL41P1, CYCSP55, HMGN2P4, TPI1P1, RPL41P5, AL162151.2, PPIAP29, HNRNPA1P4, AC016596.2, AL603825.1, RPL9P21, AC005884.2, PPIAP31, HMGN1P36, HMGN2P41, AL035411.1, RPS26P39, FABP5P7, SDHDP6, ATP5PFP1, EEF1A1P5, RPSAP8, HMGN2P3, SLC39A2, KRT8P13, RPL21P16, RPSAP15, HMGN1P38, AF279873.1, RPL7P6, AC112491.1, AC022968.1",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a step-by-step analysis to identify the cell type based on the provided marker list: **Step 1. List the Key Functional Markers:** Upon reviewing the provided list, many of the top genes are either pseudogenes (indicated by 'P' in their name, e.g., HMGN2P6, PPIAP40, RPL7P54) or uncharacterized loci (e.g., AL031284.1, AC012085.1). These are generally not informative for cell type identification as they are often expressed broadly or are transcriptional noise. Therefore, I will focus on the protein-coding genes with known functions. * **LGR5 (Leucine-rich repeat-containing G protein-coupled receptor 5):** This is a well-established and highly specific marker for actively cycling intestinal stem cells (ISCs) located at the crypt base. It is a Wnt target gene and plays a crucial role in maintaining the intestinal epithelium. * **IGFBPL1 (Insulin-like growth factor binding protein-like 1):** While not as specific as LGR5, IGFBPL1 has been implicated in various cellular processes, including cell growth and differentiation. Its role in intestinal stem cells is less directly characterized but can be associated with proliferative states. * **TDGF1 (Teratocarcinoma-derived growth factor 1, also known as Cripto-1):** This gene is a co-receptor for TGF-beta and Nodal signaling pathways, crucial for embryonic development and stem cell maintenance. It has been reported in various stem cell populations, including intestinal stem cells, where it can promote proliferation and inhibit differentiation. * **ASCL2 (Achaete-scute homolog 2):** A basic helix-loop-helix (bHLH) transcription factor, ASCL2 is a critical regulator of intestinal stem cell identity and proliferation. It is a direct target of Wnt signaling and works in concert with LGR5 to maintain the stem cell pool. * **SLC39A2 (Solute Carrier Family 39 Member 2, also known as ZIP2):** This gene encodes a zinc transporter. While zinc transport is a fundamental cellular process, specific transporters can be enriched in certain cell types. Its presence here might suggest active metabolic processes or specific requirements for zinc in this cell population, but it's not a primary cell type marker. **Step 2. List the Key Cell Type Markers:** Based on the functional markers identified above, the most prominent cell type markers are: * **LGR5:** Definitive marker for intestinal stem cells (ISCs). * **ASCL2:** Critical transcription factor for intestinal stem cell maintenance and identity. * **TDGF1:** Associated with stem cell proliferation and maintenance, often found in stem cell niches. The remaining protein-coding genes (IGFBPL1, SLC39A2) are less specific for cell type identification but can provide supporting context. The high prevalence of pseudogenes and uncharacterized loci in the top expressed list is unusual for highly specific functional markers and might indicate a very actively transcribing cell type or a specific genomic region being highly active. However, for cell type identification, we must rely on the known functional genes. **Step 3. Cross-reference Known Databases:** * **LGR5:** Widely recognized as the canonical marker for actively cycling intestinal stem cells. Numerous scRNA-seq studies of the intestine consistently use LGR5 to identify this population. (e.g., Barker et al., Nature 2007; Sato et al., Nature 2009; Haber et al., Nature 2017). * **ASCL2:** Frequently co-expressed with LGR5 in intestinal stem cells. Its role in maintaining the stem cell state is well-documented (e.g., van der Flier et al., Gastroenterology 2009; Jadhav et al., Nature 2017). * **TDGF1:** While expressed in various stem cell types, its co-expression with LGR5 and ASCL2 in the intestine further supports a stem cell identity (e.g., Blanpain et al., Cell Stem Cell 2007; Takeda et al., Cell Stem Cell 2011). * **IGFBPL1:** Some studies have shown IGFBPL1 to be expressed in certain stem cell populations or in cells undergoing proliferation, but it's not a primary defining marker for ISCs. * **SLC39A2:** Less frequently cited as a specific marker for ISCs, but its expression might reflect metabolic demands of rapidly dividing cells. The high expression of pseudogenes and uncharacterized transcripts at the top of the list is a common observation in some scRNA-seq datasets, especially in highly transcriptionally active cells. While not directly informative for cell identity, it doesn't contradict a stem cell identity, which are often metabolically and transcriptionally active. **Step 4. Determine the Most Probable General Cell Type:** The overwhelming evidence from the key functional markers, particularly the co-expression of **LGR5** and **ASCL2**, strongly points towards **Intestinal Stem Cells (ISCs)**. These two genes are the most definitive markers for this cell population in the large intestine. The presence of TDGF1 further supports this conclusion. **Step 5. Identify the Top 3 Most Probable Sub Cell Types:** Given the strong markers for intestinal stem cells, the sub-types would likely fall within the spectrum of ISC states. 1. **LGR5+ Crypt Base Columnar (CBC) Stem Cells:** This is the most probable and canonical subtype. LGR5 is the defining marker for these actively cycling, multipotent stem cells located at the very bottom of the intestinal crypts. Their primary role is to continuously replenish the intestinal epithelium. The co-expression of ASCL2 and TDGF1 perfectly aligns with this identity. 2. **Secretory-biased Intestinal Stem Cells (e.g., early secretory progenitors):** While LGR5+ CBCs are multipotent, there's evidence for heterogeneity within the stem cell pool, with some LGR5+ cells showing a slight bias towards secretory lineage differentiation (e.g., goblet cells, enteroendocrine cells). The markers provided don't strongly differentiate between a purely multipotent LGR5+ cell and one with a slight secretory bias, but it's a plausible sub-state within the LGR5+ population. However, without specific secretory lineage markers (e.g., MUC2, CHGA), this remains a less definitive call than the primary CBC identity. 3. **Quiescent/Reserve Intestinal Stem Cells (e.g., +4 cells, although less common in large intestine):** While LGR5 is primarily associated with actively cycling stem cells, some studies have suggested a population of quiescent or ""reserve"" stem cells, sometimes referred to as +4 cells (located 4 cell positions from the crypt base). These cells might express lower levels of LGR5 or other markers like Bmi1 or Hopx. However, the strong expression of *LGR5* and *ASCL2* in this list points more towards an *active* stem cell population rather than a quiescent one. Therefore, this is less likely than the CBC identity. **Most Likely Subtype:** Based on the high expression of **LGR5** and **ASCL2**, the most likely subtype is **LGR5+ Crypt Base Columnar (CBC) Stem Cells**. **Step 6. Provide a Concise Summary of Your Analysis:** The cell cluster is confidently identified as **Intestinal Stem Cells (ISCs)**, specifically **LGR5+ Crypt Base Columnar (CBC) Stem Cells**. This annotation is primarily driven by the high expression of canonical ISC markers: **LGR5** and **ASCL2**, which are critical for stem cell maintenance and proliferation in the intestinal epithelium. The presence of **TDGF1**, a known stem cell-associated growth factor, further supports this identification. While several pseudogenes and uncharacterized transcripts are highly expressed, they do not detract from the strong signal provided by these definitive protein-coding markers. The top three most probable subtypes are LGR5+ Crypt Base Columnar Stem Cells (most likely), Secretory-biased Intestinal Stem Cells, and Quiescent/Reserve Intestinal Stem Cells. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Intestinal Stem Cells (ISCs)"", ""sub_cell_types"": [ ""LGR5+ Crypt Base Columnar (CBC) Stem Cells"", ""Secretory-biased Intestinal Stem Cells"", ""Quiescent/Reserve Intestinal Stem Cells"" ], ""possible_mixed_cell_types"": [] } ```"
intestinal enteroendocrine cell,Enteroendocrine Cells,"Enteroendocrine L-cells, Enterochromaffin (EC) Cells, Immature/Developing Enteroendocrine Cells or a Mixed Enteroendocrine Population","Enteroendocrine L-cells and Enterochromaffin (EC) cells, transitional/developing enteroendocrine cell population with characteristics of both lineages",50,"GCG, PCSK1, AC090679.1, UCN3, PYY, INSL5, CHGA, LCN15, SCG2, FEV, CPLX2, NKX2-2, AL133325.3, C1orf127, LINC01014, SCGN, SLC18A1, SCG3, SCG5, TPH1, MARCH4, INSM1, RTN1, CRYBA2, SNAP25, CHGB, CRMP1, KCNB2, RFX6, AMER3, SLC32A1, CDK5R2, AVPR1B, VWA5B2, AC022893.2, ABCC8, RIMBP2, AL161658.1, COL2A1, CELF3, SCT, RIIAD1, SSTR5-AS1, RGS4, ARX, PRPH, INA, F5, AP003062.3, SLC5A8",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a step-by-step analysis to identify the cell type based on the provided marker list: **Step 1. List the Key Functional Markers:** This list is rich with genes involved in neuroendocrine function, hormone synthesis, and secretion. * **GCG (Glucagon):** A key hormone produced by alpha cells in the pancreas, but also found in enteroendocrine L-cells in the gut, where it's involved in glucose homeostasis and satiety. * **PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1):** An enzyme involved in the proteolytic processing of prohormones and proneuropeptides into their active forms. Essential for the maturation of many peptide hormones, including glucagon, insulin, and PYY. * **UCN3 (Urocortin 3):** A neuropeptide belonging to the corticotropin-releasing hormone (CRH) family. Expressed in enteroendocrine cells and involved in stress response and gut motility. * **PYY (Peptide YY):** A satiety hormone primarily secreted by L-cells in the ileum and colon in response to food intake. It slows gastric emptying and intestinal transit. * **INSL5 (Insulin-like 5):** A relaxin family peptide hormone primarily expressed in enteroendocrine L-cells of the colon, involved in gut motility and potentially glucose metabolism. * **CHGA (Chromogranin A):** A general marker for neuroendocrine cells, involved in the packaging and storage of peptide hormones and neurotransmitters in secretory vesicles. * **SCG2 (Secretogranin II), SCGN (Secretagogin), SCG3 (Secretogranin III), SCG5 (Secretogranin V/Neurosecretory protein VGF):** These are members of the granin family, like CHGA, and are involved in the storage and regulated secretion of peptide hormones and neurotransmitters in neuroendocrine cells. SCGN, in particular, is often associated with enteroendocrine cells. * **FEV (FEV Transcription Factor, ETS Family Member):** A transcription factor crucial for the development and differentiation of enteroendocrine cells, particularly those producing serotonin and other gut hormones. * **CPLX2 (Complexin 2):** A synaptic protein involved in regulating neurotransmitter release, suggesting a secretory function. * **NKX2-2 (NK2 Homeobox 2):** A transcription factor involved in the development of various neuroendocrine cell types, including pancreatic alpha and beta cells, and also found in enteroendocrine cells. * **SLC18A1 (Solute Carrier Family 18 Member A1 / VMAT1):** A vesicular monoamine transporter, responsible for packaging monoamine neurotransmitters (like serotonin) into synaptic vesicles. This strongly points towards cells capable of monoamine synthesis and secretion. * **TPH1 (Tryptophan Hydroxylase 1):** The rate-limiting enzyme in serotonin synthesis, primarily expressed in enterochromaffin (EC) cells in the gut. Its presence is a strong indicator of serotonin-producing cells. * **INSM1 (Insulinoma-associated protein 1):** A transcription factor essential for neuroendocrine cell differentiation and survival. A pan-neuroendocrine marker. * **SNAP25 (Synaptosomal-Associated Protein, 25kDa):** A component of the SNARE complex, critical for vesicle fusion and neurotransmitter/hormone release. * **CHGB (Chromogranin B):** Another member of the granin family, similar to CHGA, indicating neuroendocrine secretory function. * **SLC32A1 (Solute Carrier Family 32 Member A1 / VGAT):** A vesicular GABA transporter, suggesting the potential for GABAergic signaling, although less common in gut enteroendocrine cells compared to other markers. * **ABCC8 (ATP Binding Cassette Subfamily C Member 8):** Encodes SUR1, a subunit of the ATP-sensitive potassium channel (KATP channel), which is critical for glucose-stimulated hormone secretion in pancreatic beta cells and also found in some enteroendocrine cells. * **SCT (Secretin):** A hormone produced by S-cells in the duodenum, but its presence here could indicate a broader enteroendocrine lineage or a specific subpopulation. Secretin stimulates bicarbonate secretion from the pancreas. * **ARX (Aristaless Related Homeobox):** A transcription factor involved in the development of various neuroendocrine cell types, including pancreatic alpha cells and some enteroendocrine cells. * **PRPH (Peripherin):** An intermediate filament protein found in neurons and some neuroendocrine cells. * **INA (Internexin neuronal intermediate filament protein alpha):** Another neuronal intermediate filament protein. **Step 2. List the Key Cell Type Markers:** The markers overwhelmingly point towards an enteroendocrine lineage, specifically within the large intestine. * **GCG, PYY, INSL5, TPH1, SCT:** These are all classic hormones or enzymes associated with different enteroendocrine cell types found in the gut. GCG and PYY are characteristic of L-cells, TPH1 of enterochromaffin (EC) cells, and SCT of S-cells. The co-expression of these suggests a mixed enteroendocrine population or a cell with multipotent enteroendocrine characteristics. * **CHGA, CHGB, PCSK1, SCG2, SCGN, SCG3, SCG5, INSM1, FEV, NKX2-2, ARX, RFX6:** These are pan-neuroendocrine markers or transcription factors critical for enteroendocrine cell development and function. Their high expression confirms the neuroendocrine identity. * **SLC18A1, TPH1:** These are strong indicators of enterochromaffin (EC) cells, which are a major enteroendocrine cell type in the large intestine, responsible for serotonin production. * **UCN3, PYY, INSL5, GCG:** These are highly characteristic of L-cells, which are abundant in the large intestine and colon. **Step 3. Cross-reference Known Databases:** A quick search in scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, specific gut scRNA-seq studies) for these markers in the large intestine consistently points to enteroendocrine cells. * **GCG, PYY, INSL5, UCN3, TPH1, CHGA, PCSK1, FEV, INSM1, NKX2-2, SCGN, SLC18A1, ARX, RFX6** are all well-established markers for enteroendocrine cells in the gut, particularly in the colon/large intestine. * The co-expression of markers for different enteroendocrine subtypes (e.g., GCG/PYY/INSL5 for L-cells, TPH1/SLC18A1 for EC cells) is common in single-cell datasets, sometimes reflecting a spectrum of differentiation, plasticity, or the capture of multiple closely related subtypes within a cluster. **Step 4. Determine the Most Probable General Cell Type:** Based on the overwhelming evidence from the key functional and cell type markers, the most probable general cell type is **Enteroendocrine Cells**. The presence of multiple hormones (GCG, PYY, INSL5, SCT), enzymes for hormone processing (PCSK1), neuroendocrine secretory machinery (CHGA, CHGB, SCG family, SNAP25), and key transcription factors for neuroendocrine development (FEV, INSM1, NKX2-2, ARX, RFX6) leaves little doubt. **Step 5. Identify the Top 3 Most Probable Sub Cell Types:** Given the co-expression of markers for different enteroendocrine lineages, we need to consider the most prominent signals. 1. **Enteroendocrine L-cells:** * **Strong evidence:** High expression of **GCG, PYY, INSL5, UCN3**. These are canonical markers for L-cells, which are highly abundant in the large intestine and colon. L-cells are known for secreting PYY, GLP-1 (encoded by GCG), and INSL5. * **Supporting markers:** PCSK1 (for prohormone processing), CHGA/CHGB/SCG family (general neuroendocrine markers). 2. **Enterochromaffin (EC) Cells:** * **Strong evidence:** High expression of **TPH1** (rate-limiting enzyme for serotonin synthesis) and **SLC18A1** (vesicular monoamine transporter, for packaging serotonin). These are definitive markers for EC cells, which are the most numerous enteroendocrine cell type in the gut and the primary source of serotonin. * **Supporting markers:** CHGA/CHGB/SCG family, SNAP25 (secretory machinery). 3. **Immature/Developing Enteroendocrine Cells or a Mixed Enteroendocrine Population:** * **Strong evidence:** The co-expression of markers for distinct mature enteroendocrine subtypes (L-cells and EC cells) alongside key developmental transcription factors like **FEV, INSM1, NKX2-2, ARX, RFX6**. This suggests either a population that is still differentiating, a progenitor population with multipotent enteroendocrine potential, or a cluster that encompasses a spectrum of enteroendocrine cells, including both L-cells and EC cells, which are often found in close proximity or even share some developmental pathways. The high expression of pan-neuroendocrine markers (CHGA, CHGB, SCG family) further supports this. **Most Likely Subtype:** Based on the combined high expression of **GCG, PYY, INSL5, UCN3** (L-cell markers) and **TPH1, SLC18A1** (EC cell markers), it is most likely a **mixed population of Enteroendocrine L-cells and Enterochromaffin (EC) cells, or a transitional/developing enteroendocrine cell population with characteristics of both lineages.** However, if forced to pick a single dominant subtype, the presence of multiple L-cell specific hormones (PYY, INSL5, GCG) alongside the strong EC cell markers (TPH1, SLC18A1) suggests a significant contribution from both. Given that L-cells are particularly abundant in the large intestine and colon, and EC cells are the most numerous overall, a cluster representing a significant proportion of both is highly plausible. Considering the ranking, GCG, PYY, INSL5 are very high, indicating a strong L-cell component. TPH1 is also present, but slightly lower. Therefore, I would lean towards **Enteroendocrine L-cells with a significant enterochromaffin (EC) cell component, or a broader enteroendocrine cluster encompassing these major subtypes.** **Refined Most Likely Subtype:** **Enteroendocrine L-cells.** While EC cell markers are present (TPH1, SLC18A1), the very high ranking of GCG, PYY, and INSL5, which are highly specific to L-cells in the large intestine, suggests that L-cells are a dominant or highly active component of this cluster. The presence of developmental transcription factors and pan-neuroendocrine markers supports the overall enteroendocrine identity. **Step 6. Provide a Concise Summary of Your Analysis:** This cell cluster from the human large intestine is unequivocally identified as **Enteroendocrine Cells**. The marker list is dominated by genes crucial for neuroendocrine function, hormone synthesis, and secretion. Key markers like GCG, PYY, INSL5, and UCN3 strongly indicate the presence of **L-cells**, which are abundant in the large intestine and secrete satiety hormones. Concurrently, the expression of TPH1 and SLC18A1 points to the presence of **Enterochromaffin (EC) cells**, the primary source of serotonin in the gut. Pan-neuroendocrine markers (CHGA, CHGB, SCG family, PCSK1, SNAP25) and critical developmental transcription factors (FEV, INSM1, NKX2-2, ARX, RFX6) further solidify the enteroendocrine identity and suggest a potentially mixed or differentiating population. The most probable specific subtype is **Enteroendocrine L-cells**, given the high ranking of their characteristic hormones, with a notable contribution from Enterochromaffin cells. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Enteroendocrine Cells"", ""sub_cell_types"": [ ""Enteroendocrine L-cells"", ""Enterochromaffin (EC) Cells"", ""Immature/Developing Enteroendocrine Cells or a Mixed Enteroendocrine Population"" ], ""possible_mixed_cell_types"": [ ""Enteroendocrine L-cells and Enterochromaffin (EC) cells"", ""transitional/developing enteroendocrine cell population with characteristics of both lineages"" ] } ```"
monocyte,Neural Crest-Derived Cells,"Schwann Cells / Myelinating Enteric Glia, Enteric Neurons, Neural Crest Progenitor Cells / Enteric Neural Stem Cells","Schwann Cells / Myelinating Enteric Glia, Enteric Neurons, Neural Crest Progenitor Cells / Enteric Neural Stem Cells",50,"NKAIN3, SPP1, CDH19, TSPAN11, PLP1, L1CAM, MYOT, IGSF11, NRXN1, SLC35F1, AL136298.1, SFRP5, Z97205.2, AL358216.1, SOX10, MEGF10, SYT10, CADM2, SLITRK2, SOX2, CRTAC1, CHL1, ZNF536, FOXD3, PTPRZ1, GRIK3, TUBB2B, CMTM5, LINC01436, TTYH1, ADARB2, CDH2, TENM3, WNT6, ATP1A2, NRXN3, KCNMB4, TMEM132B, LPL, GFRA2, CHADL, FLRT1, CHST9, GJC3, Z95114.1, RHAG, FOXD3-AS1, BMS1P10, FAM19A5, FGFBP2",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Okay, I'm ready to perform a comprehensive single-cell RNA sequencing annotation for the provided cluster of cells from human large intestine tissue. I will follow the steps outlined to provide a detailed and specific analysis. **Marker List:** NKAIN3, SPP1, CDH19, TSPAN11, PLP1, L1CAM, MYOT, IGSF11, NRXN1, SLC35F1, AL136298.1, SFRP5, Z97205.2, AL358216.1, SOX10, MEGF10, SYT10, CADM2, SLITRK2, SOX2, CRTAC1, CHL1, ZNF536, FOXD3, PTPRZ1, GRIK3, TUBB2B, CMTM5, LINC01436, TTYH1, ADARB2, CDH2, TENM3, WNT6, ATP1A2, NRXN3, KCNMB4, TMEM132B, LPL, GFRA2, CHADL, FLRT1, CHST9, GJC3, Z95114.1, RHAG, FOXD3-AS1, BMS1P10, FAM19A5, FGFBP2 --- **Step 1: List the Key Functional Markers** This step focuses on genes that indicate general cellular processes, signaling pathways, or broader functional categories, rather than specific cell identities. * **SPP1 (Secreted Phosphoprotein 1 / Osteopontin):** Involved in cell adhesion, migration, and immune regulation. Often associated with inflammatory responses, tissue remodeling, and can be expressed by various cell types including macrophages, fibroblasts, and some epithelial cells, as well as neural cells in certain contexts. * **PLP1 (Proteolipid Protein 1):** A major component of myelin in the central and peripheral nervous systems. Its presence strongly suggests myelinating cells. * **L1CAM (L1 Cell Adhesion Molecule):** A neuronal cell adhesion molecule involved in neuron migration, differentiation, and axon guidance. Also expressed in some epithelial and tumor cells, but its strong association is with the nervous system. * **NRXN1 (Neurexin 1):** A presynaptic cell adhesion molecule crucial for synapse formation and function. A definitive neuronal marker. * **SLC35F1 (Solute Carrier Family 35 Member F1):** A transporter protein, its specific functional role in cell identity is less direct but indicates active transport processes. * **SFRP5 (Secreted Frizzled-Related Protein 5):** A Wnt signaling pathway modulator. Wnt signaling is critical for development, cell proliferation, and differentiation in many tissues, including the gut and nervous system. * **MEGF10 (Multiple Epidermal Growth Factor-like Domains 10):** Involved in cell adhesion and phagocytosis. Expressed in various cell types, including glial cells. * **SYT10 (Synaptotagmin 10):** A member of the synaptotagmin family, typically involved in calcium-dependent membrane trafficking and neurotransmitter release, suggesting neuronal or neuroendocrine activity. * **CADM2 (Cell Adhesion Molecule 2):** A neuronal cell adhesion molecule involved in synapse formation. * **SLITRK2 (SLIT and NTRK-like Family Member 2):** Involved in neuronal development and synapse formation. * **SOX2 (SRY-Box Transcription Factor 2):** A key transcription factor involved in maintaining pluripotency and stem cell identity, particularly in neural stem cells and some epithelial stem cells. Its presence is significant. * **PTPRZ1 (Protein Tyrosine Phosphatase Receptor Type Z1):** A receptor-type protein tyrosine phosphatase expressed in the central nervous system, involved in neuronal development and glial cell function. * **GRIK3 (Glutamate Ionotropic Receptor Kainate Type Subunit 3):** A subunit of kainate receptors, which are ionotropic glutamate receptors. Strongly indicative of neuronal cells. * **TUBB2B (Tubulin Beta 2B Class IIb):** A beta-tubulin isoform predominantly expressed in neurons, involved in microtubule formation and neuronal migration. * **ADARB2 (Adenosine Deaminase RNA Specific B2):** Involved in RNA editing, particularly in the nervous system. * **CDH2 (Cadherin 2 / N-cadherin):** A cell adhesion molecule important in neural development, synapse formation, and maintaining cell-cell contacts in various tissues. * **TENM3 (Teneurin Transmembrane Protein 3):** Involved in neural development, axon guidance, and synapse formation. * **WNT6 (Wnt Family Member 6):** Another Wnt signaling ligand, involved in developmental processes and tissue homeostasis. * **ATP1A2 (ATPase Na+/K+ Transporting Subunit Alpha 2):** A subunit of the Na+/K+-ATPase pump, crucial for maintaining ion gradients and neuronal excitability. * **NRXN3 (Neurexin 3):** Another member of the neurexin family, involved in synapse formation. * **KCNMB4 (Potassium Calcium-Activated Channel Subfamily M Beta Member 4):** A regulatory subunit of large conductance calcium-activated potassium channels, important for neuronal excitability. * **TMEM132B (Transmembrane Protein 132B):** Implicated in neuronal function and psychiatric disorders. * **LPL (Lipoprotein Lipase):** Involved in lipid metabolism. While not directly a cell identity marker, it can be expressed by various cells including adipocytes, muscle cells, and some glial cells. * **GFRA2 (GDNF Family Receptor Alpha 2):** A receptor for glial cell line-derived neurotrophic factor (GDNF) family ligands, important for neuronal survival and differentiation. * **FLRT1 (Fibronectin Leucine Rich Transmembrane Protein 1):** Involved in cell adhesion and neuronal development. * **CHST9 (Carbohydrate Sulfotransferase 9):** Involved in glycosaminoglycan biosynthesis, which can play roles in extracellular matrix and cell signaling. * **GJC3 (Gap Junction Protein Gamma 3):** A connexin, forming gap junctions for intercellular communication. * **FAM19A5 (Family With Sequence Similarity 19 Member A5):** A secreted neurotrophic factor. * **FGFBP2 (Fibroblast Growth Factor Binding Protein 2):** Binds FGFs, modulating their activity, involved in cell proliferation and differentiation. --- **Step 2: List the Key Cell Type Markers** This step focuses on genes that are more specific indicators of particular cell types or lineages. * **NKAIN3 (Na+/K+ ATPase Interacting 3):** While its exact role in cell identity is still being elucidated, it has been observed in neuronal contexts. * **CDH19 (Cadherin 19):** A cadherin family member, less commonly cited as a primary cell type marker, but cadherins are crucial for cell-cell adhesion and tissue architecture. Some studies link it to neural crest derivatives. * **TSPAN11 (Tetraspanin 11):** Tetraspanins are involved in cell surface organization and signaling. Its specificity to a particular cell type is not universally strong, but it can be expressed in various cells. * **PLP1 (Proteolipid Protein 1):** **Strong marker for oligodendrocytes (CNS) and Schwann cells (PNS)**, which are myelinating glial cells. * **L1CAM (L1 Cell Adhesion Molecule):** **Strong marker for neurons and neural crest-derived cells.** * **IGSF11 (Immunoglobulin Superfamily Member 11):** Expressed in various tissues, including brain, and can be involved in cell adhesion. * **NRXN1 (Neurexin 1):** **Strong marker for neurons**, particularly at presynaptic terminals. * **SOX10 (SRY-Box Transcription Factor 10):** **A master regulator transcription factor for neural crest development, Schwann cells, oligodendrocytes, and melanocytes.** Its presence is highly significant for neural crest-derived lineages. * **SOX2 (SRY-Box Transcription Factor 2):** While a stem cell marker, in the context of neural markers, it is also a **marker for neural stem cells and progenitor cells.** * **FOXD3 (Forkhead Box D3):** **A key transcription factor involved in neural crest development and maintenance of neural crest stem cells.** Its co-expression with SOX10 is highly indicative of neural crest lineage. * **CHL1 (Cell Adhesion Molecule L1 Like):** A neuronal cell adhesion molecule, related to L1CAM, involved in axon guidance and neuronal migration. * **ZNF536 (Zinc Finger Protein 536):** A transcription factor, less commonly used as a primary cell type marker, but can be involved in neuronal development. * **CRTAC1 (Cartilage Associated Protein 1):** While its name suggests cartilage, it has also been found in neural tissues and can be associated with neural development. * **TTYH1 (Tweety Homolog 1):** A calcium-activated chloride channel, expressed in various tissues including the brain, and can be involved in neuronal excitability. * **CHADL (Chondroadherin Like):** While related to cartilage, its expression in other tissues, including neural, has been reported. * **RHAG (Rh Associated Glycoprotein):** Primarily known for its role in red blood cells, but also expressed in other tissues, including brain, where it might be involved in ammonia transport. --- **Step 3: Cross-reference Known Databases and Literature** The co-expression of several key markers immediately points towards a neural crest-derived lineage, specifically cells associated with the peripheral nervous system (PNS) or enteric nervous system (ENS), which is a part of the PNS located within the gut wall. * **SOX10, FOXD3, L1CAM, PLP1, NRXN1, SOX2:** This combination is highly characteristic of neural crest-derived cells. * **SOX10 and FOXD3** are crucial transcription factors for neural crest specification and maintenance. * **PLP1** is a definitive marker for myelinating glial cells (Schwann cells in the PNS, oligodendrocytes in the CNS). Given the large intestine context, Schwann cells are highly probable. * **L1CAM and NRXN1** are strong neuronal adhesion molecules. * **SOX2** indicates a progenitor or stem cell state within this neural lineage. * **Enteric Nervous System (ENS) Context:** The large intestine is rich in the ENS, often referred to as the ""second brain,"" which is derived from the neural crest. The ENS contains neurons, glial cells (enteric glial cells, EGCs), and progenitor cells. * **Schwann Cells/Enteric Glia:** The presence of **PLP1** is a very strong indicator of myelinating cells. In the PNS (which includes the ENS), these are Schwann cells. Enteric glial cells (EGCs) share many characteristics with astrocytes and Schwann cells and are also neural crest-derived. While PLP1 is a classic Schwann cell marker, EGCs can express some glial markers. However, the strong presence of PLP1 leans heavily towards myelinating Schwann cells. * **Neurons:** The presence of **NRXN1, L1CAM, GRIK3, SYT10, CADM2, SLITRK2, TENM3, ATP1A2, NRXN3, KCNMB4, TUBB2B, ADARB2, FAM19A5** strongly indicates the presence of neuronal components or cells with neuronal characteristics. * **Neural Progenitors/Stem Cells:** **SOX2** and **FOXD3** suggest a population that includes neural stem cells or progenitors, which are known to exist in the ENS. * **Other Markers:** * **SPP1:** Can be expressed by various cells, including some neural cells, and can be involved in neural plasticity and inflammation. * **MEGF10:** Expressed in glial cells, including astrocytes and microglia. * **PTPRZ1:** Expressed in the CNS by oligodendrocytes and astrocytes, and in the PNS by Schwann cells. --- **Step 4: Determine the Most Probable General Cell Type** Based on the overwhelming evidence from the key functional and cell type markers, the most probable general cell type is **Neural Crest-Derived Cells**, specifically components of the **Peripheral Nervous System (PNS)**, which in the large intestine context, primarily refers to the **Enteric Nervous System (ENS)**. The strong co-expression of SOX10, FOXD3, PLP1, L1CAM, NRXN1, and numerous other neuronal and glial markers unequivocally points to this lineage. --- **Step 5: Identify the Top 3 Most Probable Sub Cell Types** Given the general cell type (ENS/PNS neural crest derivatives) and the specific markers, we can infer the following sub-cell types: 1. **Schwann Cells / Myelinating Enteric Glia (Most Likely):** * **Key Markers:** **PLP1** (definitive myelin marker), **SOX10** (master regulator of Schwann cell development), **FOXD3**, **PTPRZ1**, **MEGF10**, **L1CAM** (can be expressed by Schwann cells, especially during development/regeneration). The high expression of PLP1 is particularly compelling for myelinating cells. While ""enteric glial cells"" is a broad term, the presence of PLP1 suggests a more specialized myelinating glial cell, akin to Schwann cells in the ENS. 2. **Enteric Neurons (Highly Likely):** * **Key Markers:** **NRXN1, L1CAM, GRIK3, SYT10, CADM2, SLITRK2, TENM3, ATP1A2, NRXN3, KCNMB4, TUBB2B, ADARB2, FAM19A5**. These are all strong indicators of neuronal identity and function, including synapse formation, neurotransmission, and neuronal excitability. The ENS is densely populated with various types of neurons. 3. **Neural Crest Progenitor Cells / Enteric Neural Stem Cells (Likely):** * **Key Markers:** **SOX2** (neural stem cell marker), **FOXD3** (neural crest stem cell maintenance), **SOX10** (neural crest lineage). The presence of these transcription factors suggests a population with progenitor potential, capable of differentiating into neurons and glia within the ENS. **Most Likely Subtype:** The most likely subtype, given the highest ranked markers, is **Schwann Cells / Myelinating Enteric Glia**. The presence of **PLP1** as a highly expressed marker (ranked 5th) is a very strong and specific indicator for myelinating cells. While there are many neuronal markers, the prominence of PLP1, combined with SOX10 and FOXD3, points to a significant glial component, specifically those involved in myelination. It's possible this cluster represents a mixed population with a strong glial signature, or a specific stage of glial development/function. --- **Step 6: Provide a Concise Summary of Your Analysis** This cell cluster from the human large intestine is unequivocally identified as **Neural Crest-Derived Cells**, specifically components of the **Enteric Nervous System (ENS)**. The robust co-expression of master neural crest transcription factors **SOX10** and **FOXD3**, alongside the definitive myelinating glial marker **PLP1**, and numerous neuronal markers such as **NRXN1, L1CAM, and GRIK3**, strongly supports this annotation. The most probable general cell type is **Peripheral Nervous System (PNS) / Enteric Nervous System (ENS) cells**. The top three most probable sub-cell types are: 1. **Schwann Cells / Myelinating Enteric Glia** (Most Likely, due to high PLP1 expression). 2. **Enteric Neurons**. 3. **Neural Crest Progenitor Cells / Enteric Neural Stem Cells**. The presence of **PLP1** among the top markers makes **Schwann Cells / Myelinating Enteric Glia** the most likely primary subtype within this cluster, suggesting a significant population of myelin-forming cells or cells with strong myelin-related gene expression within the ENS. This cluster likely represents a heterogeneous population encompassing both glial and neuronal elements, potentially including progenitor cells, all originating from the neural crest within the large intestine. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Neural Crest-Derived Cells"", ""sub_cell_types"": [""Schwann Cells / Myelinating Enteric Glia"", ""Enteric Neurons"", ""Neural Crest Progenitor Cells / Enteric Neural Stem Cells""], ""possible_mixed_cell_types"": [""Schwann Cells / Myelinating Enteric Glia"", ""Enteric Neurons"", ""Neural Crest Progenitor Cells / Enteric Neural Stem Cells""] } ```"
plasma cell,Plasma Cells,"IgA-secreting Plasma Cells (Mucosal Plasma Cells), IgG-secreting Plasma Cells, Transitional/Early Plasma Cells (or IgM-secreting Plasma Cells)",,50,"IGLL5, IGLV6-57, JCHAIN, FAM92B, IGLC3, IGLC2, IGHV3-7, IGKC, TNFRSF17, IGHG1, AC026369.3, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MYL2, MZB1, IGHG3, IGHV3-74, IGHM, ANKRD36BP2, AMPD1, IGKV3-20, IGHA2, DERL3, AC104699.1, LINC02362, AL391056.1, LILRB4, CCL3, BMP6, UBE2QL1, LINC00309, AL133467.1, GPRC5D, FCRL5, DNAAF1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, TXNDC5, LINC02384, CCR10, BFSP2, APOBEC3A, AC106897.1",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a step-by-step analysis to identify the cell type based on the provided marker list: ## Step 1: List the Key Functional Markers The provided list is overwhelmingly dominated by immunoglobulin-related genes. These genes are directly involved in the production and secretion of antibodies, which is the primary function of B cells, particularly plasma cells. * **IGLL5 (Immunoglobulin Lambda-Like Polypeptide 5):** A surrogate light chain component, often expressed in pre-B cells and plasma cells, indicating B cell lineage and differentiation. * **IGLV6-57, IGLC3, IGLC2, IGHV3-7, IGKC, IGHG1, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, IGHG3, IGHV3-74, IGHM, IGKV3-20, IGHA2:** These are various immunoglobulin heavy chain (IGHV, IGHG, IGHM, IGHA) and light chain (IGLV, IGLC, IGKC, IGKV) variable and constant region genes. Their high and diverse expression is a hallmark of antibody-producing cells. * **IGHG1, IGHG3:** Indicate IgG class switching, characteristic of mature plasma cells. * **IGHA1, IGHA2:** Indicate IgA class switching, particularly relevant in mucosal tissues like the large intestine. * **IGHM:** Indicates IgM production, which can be found in early plasma cells or B cells. * **JCHAIN (Joining Chain of Multimeric IgA and IgM):** Essential for the polymerization of IgA and IgM into dimeric or pentameric forms, crucial for their function in mucosal immunity. Its presence strongly points towards IgA- or IgM-producing plasma cells. * **TNFRSF17 (B Cell Maturation Antigen, BCMA):** A receptor expressed on plasma cells and some activated B cells, involved in plasma cell survival and differentiation. * **MZB1 (Marginal Zone B and B1 Cell Specific Protein):** Involved in immunoglobulin secretion and plasma cell differentiation. Its expression is characteristic of plasma cells. * **DERL3 (Derlin 3):** Involved in endoplasmic reticulum-associated degradation (ERAD), which is highly active in cells with extensive protein synthesis and secretion, like plasma cells. * **FCRL5 (Fc Receptor Like 5):** Expressed on a subset of B cells and plasma cells, potentially involved in regulating B cell activation and antibody production. ## Step 2: List the Key Cell Type Markers Based on the functional markers, the key cell type markers are predominantly related to B lymphocytes and, more specifically, plasma cells. * **IGLL5, IGLV6-57, JCHAIN, IGLC3, IGLC2, IGHV3-7, IGKC, TNFRSF17, IGHG1, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MZB1, IGHG3, IGHV3-74, IGHM, IGKV3-20, IGHA2:** These are all direct markers of B cell lineage and, given their diversity and the presence of constant regions, strongly indicate a terminally differentiated, antibody-secreting cell type (plasma cell). * **GPRC5D (G Protein-Coupled Receptor Class C Group 5 Member D):** While not exclusively a plasma cell marker, it has been identified as a surface marker on plasma cells and is a target for multiple myeloma therapies, reinforcing the plasma cell identity. * **CCL3 (Chemokine (C-C motif) Ligand 3):** While not a specific cell type marker, chemokines can be produced by various immune cells, including plasma cells, to attract other immune cells. * **LILRB4 (Leukocyte Immunoglobulin Like Receptor B4):** Also known as CD85k or ILT3, expressed on monocytes, macrophages, and dendritic cells, but also found on some B cells and plasma cells, particularly in certain inflammatory contexts. Its presence here might indicate a specific activation state or interaction with other immune cells. * **CCR10 (C-C Chemokine Receptor Type 10):** Expressed on various immune cells, including B cells and plasma cells, and is involved in homing to mucosal tissues like the gut. This is a strong indicator for plasma cells in the large intestine. Genes like **FAM92B, AC026369.3, ANKRD36BP2, AMPD1, AC104699.1, LINC02362, AL391056.1, UBE2QL1, LINC00309, AL133467.1, DNAAF1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, TXNDC5, LINC02384, BFSP2, APOBEC3A, AC106897.1** are either less specific, non-coding RNAs, or genes with broader expression patterns that do not strongly contradict the primary cell type inference. **MYL2** (Myosin Light Chain 2) is typically associated with muscle cells, and its presence here might be due to low-level expression in other cell types or potential contamination, but it is heavily outweighed by the strong immunoglobulin signature. **BMP6** (Bone Morphogenetic Protein 6) is involved in various developmental processes and can be expressed by different cell types, including immune cells, but is not a primary marker for plasma cells. ## Step 3: Cross-reference Known Databases A rapid search in scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker, Azimuth) for these markers consistently points to plasma cells or antibody-secreting cells. * **High expression of multiple IGHV, IGLV, IGHG, IGHA, IGHM, IGKC, IGLC genes:** Universally recognized as markers for B cells, with the diversity and constant region expression indicating plasma cells. * **JCHAIN, TNFRSF17 (BCMA), MZB1, GPRC5D:** All are well-established markers for plasma cells in various tissues, including the gut. * **CCR10:** Known to be expressed by gut-homing plasma cells. * **DERL3:** Often upregulated in plasma cells due to high ER stress from antibody production. The co-expression of these markers, particularly the immunoglobulin genes, JCHAIN, BCMA, and MZB1, is a definitive signature of plasma cells. The presence of both IgA (IGHA1, IGHA2) and IgG (IGHG1, IGHG3) constant regions indicates class-switched plasma cells, which are common in the gut. ## Step 4: Determine the Most Probable General Cell Type Based on the overwhelming evidence from the key functional and cell type markers, the most probable general cell type is **Plasma Cells**. ## Step 5: Identify the Top 3 Most Probable Sub Cell Types Given the tissue (large intestine) and the specific markers, we can infer more specific subtypes of plasma cells. 1. **IgA-secreting Plasma Cells (Mucosal Plasma Cells):** * **Reasoning:** The high expression of **IGHA1** and **IGHA2** (Immunoglobulin Alpha heavy chain constant regions) along with **JCHAIN** is a strong indicator of IgA-producing plasma cells. IgA is the predominant antibody isotype in mucosal tissues like the large intestine, playing a critical role in gut immunity. The presence of **CCR10** further supports their gut-homing phenotype. 2. **IgG-secreting Plasma Cells:** * **Reasoning:** The presence of **IGHG1** and **IGHG3** (Immunoglobulin Gamma heavy chain constant regions) indicates IgG production. While IgA is dominant in the gut, IgG-secreting plasma cells are also present and contribute to systemic and local immunity, especially during inflammation or infection. 3. **Transitional/Early Plasma Cells (or IgM-secreting Plasma Cells):** * **Reasoning:** The presence of **IGHM** (Immunoglobulin Mu heavy chain constant region) suggests the presence of cells that might be earlier in the plasma cell differentiation pathway or are still producing IgM. While less abundant than IgA or IgG plasma cells in the mature gut, they can be present. The high expression of **IGLL5** (a surrogate light chain component) can also be associated with early B cell development and differentiation towards plasma cells. **Most Likely Subtype:** Based on the strong expression of **IGHA1, IGHA2, and JCHAIN** in the context of the large intestine, the most likely subtype is **IgA-secreting Plasma Cells (Mucosal Plasma Cells)**. These cells are crucial for maintaining gut homeostasis and defending against pathogens at mucosal surfaces. ## Step 6: Provide a Concise Summary of Your Analysis The cell cluster is definitively identified as **Plasma Cells**. This annotation is strongly supported by the high and diverse expression of numerous immunoglobulin heavy and light chain genes (e.g., IGHV, IGLV, IGHG1, IGHA1, IGHM, IGKC, IGLC), along with key plasma cell-specific markers such as **JCHAIN**, **TNFRSF17 (BCMA)**, **MZB1**, and **GPRC5D**. The presence of **IGHA1** and **IGHA2** in conjunction with **JCHAIN** and **CCR10** strongly suggests a prominent population of **IgA-secreting Plasma Cells** specialized for mucosal immunity in the large intestine. The detection of **IGHG1** and **IGHG3** also indicates the presence of IgG-producing plasma cells. Overall, the marker profile is a classic signature of terminally differentiated, antibody-secreting B cells, with a strong emphasis on IgA production, consistent with their location in the gut mucosa. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Plasma Cells"", ""sub_cell_types"": [ ""IgA-secreting Plasma Cells (Mucosal Plasma Cells)"", ""IgG-secreting Plasma Cells"", ""Transitional/Early Plasma Cells (or IgM-secreting Plasma Cells)"" ], ""possible_mixed_cell_types"": [] } ```"
transit amplifying cell of large intestine,Proliferating Epithelial Cells,"Transit-Amplifying (TA) Cells, Intestinal Stem Cells (ISCs), Proliferating Enterocyte Progenitors",,50,"HJURP, UBE2C, CENPA, PBK, AURKB, DLGAP5, CKAP2L, KIF2C, KIF15, BIRC5, SPC25, ASPM, KIF18B, CEP55, DEPDC1, MKI67, CDC45, CDCA5, TOP2A, PCLAF, MND1, RRM2, ZNF695, CCNB2, NUF2, SKA3, SPC24, DTL, PKMYT1, CDCA3, TTK, DIAPH3, PLK1, IQGAP3, CDK1, TK1, POLQ, GTSE1, OIP5, FOXM1, TROAP, SKA1, NEK2, CDC25C, NCAPG, PIMREG, GINS2, RAD51AP1, CDT1, CCNA2",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Okay, I will analyze the provided list of highly expressed markers from a single-cell cluster in human large intestine tissue to identify the cell type. ## Step-by-Step Analysis: ### 1. List the Key Functional Markers: The vast majority of the genes in this list are intimately involved in cell cycle progression, DNA replication, and mitosis. This immediately points towards a highly proliferative cell population. * **Cell Cycle Regulators/Mitosis:** * **UBE2C:** Ubiquitin-conjugating enzyme E2 C, crucial for mitotic progression and degradation of cell cycle proteins. * **CENPA:** Centromere protein A, a histone H3 variant essential for centromere identity and kinetochore assembly. * **PBK (TOPK):** PDZ binding kinase, involved in cell proliferation and survival, particularly in mitosis. * **AURKB:** Aurora kinase B, a key regulator of mitosis, involved in chromosome segregation and cytokinesis. * **DLGAP5 (HURP):** DLG associated protein 5, involved in spindle assembly and stability during mitosis. * **CKAP2L:** Cytoskeleton associated protein 2 like, involved in microtubule organization and cell division. * **KIF2C (MCAK):** Kinesin family member 2C, a microtubule depolymerase critical for chromosome segregation. * **KIF15:** Kinesin family member 15, involved in spindle assembly and maintenance. * **BIRC5 (Survivin):** Baculoviral IAP repeat containing 5, an anti-apoptotic protein highly expressed in proliferating cells, crucial for mitosis. * **SPC25, SPC24:** Spindle pole body component 25 and 24, part of the NDC80 kinetochore complex, essential for chromosome segregation. * **ASPM:** Asparagine synthetase, involved in spindle pole integrity and neurogenesis, often a marker of proliferating cells. * **KIF18B:** Kinesin family member 18B, involved in chromosome alignment and segregation. * **CEP55:** Centrosomal protein 55kDa, involved in cytokinesis. * **DEPDC1:** DEP domain containing 1, involved in cell cycle progression and proliferation. * **MKI67 (Ki-67):** Marker of proliferation Ki-67, a classic and widely used marker for actively proliferating cells. Its high expression is a strong indicator of cell division. * **CDC45:** Cell division cycle 45, essential for initiation of DNA replication. * **CDCA5 (Sororin):** Cell division cycle associated 5, involved in sister chromatid cohesion. * **TOP2A:** DNA topoisomerase II alpha, essential for DNA replication, chromosome condensation, and segregation. * **PCLAF (PCNA-associated factor):** PCNA-associated factor, involved in DNA replication and repair. * **MND1:** Meiotic nuclear division 1, involved in homologous recombination and DNA repair, often co-expressed with proliferation markers. * **RRM2:** Ribonucleotide reductase M2, essential for DNA synthesis by providing dNTPs. * **CCNB2:** Cyclin B2, a mitotic cyclin, crucial for entry into and progression through mitosis. * **NUF2:** NDC80 kinetochore complex component, essential for chromosome segregation. * **SKA3, SKA1:** Spindle and kinetochore associated 3 and 1, involved in kinetochore-microtubule attachment. * **DTL (CDT2):** Denticleless E3 ubiquitin protein ligase homolog, involved in DNA replication and cell cycle control. * **PKMYT1:** Protein kinase, membrane associated tyrosine/threonine 1, a mitotic kinase that regulates CDK1. * **CDCA3:** Cell division cycle associated 3, involved in cell cycle progression. * **TTK (MPS1):** TTK protein kinase, a key component of the spindle assembly checkpoint. * **DIAPH3:** Diaphanous related formin 3, involved in cytokinesis. * **PLK1:** Polo-like kinase 1, a master regulator of multiple mitotic events. * **IQGAP3:** IQ motif containing GTPase activating protein 3, involved in cell proliferation and migration. * **CDK1 (CDC2):** Cyclin dependent kinase 1, the master regulator of mitotic entry and progression. * **TK1:** Thymidine kinase 1, involved in DNA synthesis. * **POLQ:** DNA polymerase theta, involved in DNA repair, often upregulated in proliferating cells. * **GTSE1:** G2 and S phase expressed 1, involved in cell cycle regulation. * **OIP5 (LINC00261):** Opa interacting protein 5, involved in cell cycle progression. * **FOXM1:** Forkhead box protein M1, a transcription factor that regulates the expression of many genes involved in cell cycle progression and mitosis. Often considered a master regulator of proliferation. * **TROAP:** Trophinin associated protein, involved in cytokinesis. * **NEK2:** NIMA related kinase 2, involved in centrosome separation and spindle formation. * **CDC25C:** Cell division cycle 25C, a phosphatase that activates CDK1. * **NCAPG:** Non-SMC condensin I complex subunit G, involved in chromosome condensation. * **PIMREG:** PIM1 proto-oncogene, serine/threonine kinase regulator, involved in cell cycle progression. * **GINS2:** GINS complex subunit 2, essential for DNA replication initiation and elongation. * **RAD51AP1:** RAD51 associated protein 1, involved in homologous recombination and DNA repair. * **CDT1:** Chromatin licensing and DNA replication factor 1, essential for DNA replication initiation. * **CCNA2:** Cyclin A2, involved in both S phase and M phase progression. * **Other/Less Specific:** * **HJURP:** Holliday junction recognition protein, involved in CENP-A deposition at centromeres, linking it to cell division. * **ZNF695:** Zinc finger protein 695, less directly linked to core cell cycle machinery, but its presence in this context might suggest a role in regulating proliferation-related genes. **Summary of Functional Markers:** The overwhelming majority of these markers are directly involved in DNA replication, cell cycle progression (especially S and M phases), chromosome dynamics, and cytokinesis. This strongly indicates a highly proliferative cell population. ### 2. List the Key Cell Type Markers: This list is almost exclusively composed of cell cycle-related genes and lacks typical lineage-specific markers for differentiated cells of the large intestine (e.g., epithelial cell markers like EPCAM, mucins; immune cell markers like CD3, CD19; stromal markers like ACTA2, PDGFRA; or neuronal markers). The absence of specific differentiated cell markers, combined with the strong proliferation signature, suggests that these cells are either: a. Undifferentiated progenitor/stem cells. b. Differentiated cells that are actively undergoing division (e.g., rapidly renewing epithelial cells). ### 3. Cross-reference Known Databases: Searching these gene lists (especially the top markers like HJURP, UBE2C, CENPA, PBK, AURKB, DLGAP5, BIRC5, MKI67, TOP2A, FOXM1, CDK1, PLK1, RRM2, CCNB2, CCNA2) in scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker) consistently points to ""proliferating cells,"" ""cycling cells,"" ""stem cells,"" or ""progenitor cells"" across various tissues, including the intestine. For instance, MKI67, TOP2A, and BIRC5 are canonical markers for proliferating cells in virtually all tissues. FOXM1 is a well-known transcription factor driving proliferation. In the context of the large intestine, the most rapidly proliferating cell populations are: * **Intestinal Stem Cells (ISCs):** Located at the crypt base, these are multipotent cells responsible for renewing the entire intestinal epithelium. They are highly proliferative. * **Transit-Amplifying (TA) Cells:** These are daughter cells of ISCs that undergo several rounds of rapid division as they migrate up the crypt-villus axis before differentiating. They are also highly proliferative. * **Activated Immune Cells:** While some immune cells can proliferate (e.g., activated T cells), the sheer breadth and intensity of the cell cycle gene expression here are more characteristic of epithelial progenitors. Also, there are no specific immune cell markers. * **Cancer Cells:** Cancer cells are characterized by uncontrolled proliferation and would show a similar gene expression profile. However, without additional context (e.g., tumor vs. healthy tissue), we assume a healthy tissue context. ### 4. Determine the Most Probable General Cell Type: Based on the overwhelming expression of genes involved in cell cycle progression, DNA replication, and mitosis, the most probable general cell type is **Proliferating Epithelial Cells**. ### 5. Identify the Top 3 Most Probable Sub Cell Types: Given the tissue (large intestine) and the strong proliferative signature, the most likely subtypes are related to the epithelial renewal process. 1. **Transit-Amplifying (TA) Cells:** These cells are characterized by rapid and extensive proliferation as they move up the crypt. They represent the bulk of actively dividing cells in the intestinal crypts. The high expression of a broad range of mitotic and DNA synthesis genes is highly consistent with TA cells. 2. **Intestinal Stem Cells (ISCs):** While ISCs are proliferative, they often exhibit a slightly less robust and more controlled proliferative signature compared to TA cells, and they would typically co-express specific stem cell markers (e.g., LGR5, OLFM4, ASCL2, SMOC2). However, given the strong proliferative signature, a subset of highly active ISCs could contribute to this cluster, or the cluster might represent a continuum including both ISCs and early TA cells. The absence of canonical ISC markers in the *top* ranked list makes them slightly less likely than pure TA cells to be the *sole* component, but they are certainly a strong candidate for a significant proportion of the cluster. 3. **Proliferating Enterocyte Progenitors:** These are a subset of TA cells that are committed to the enterocyte lineage but are still actively dividing. They would share the strong proliferative signature. This is essentially a more specific categorization within the broader TA cell population. **Most Likely Subtype:** The most likely subtype is **Transit-Amplifying (TA) Cells**. The sheer number and high expression of genes directly involved in active, rapid cell division (e.g., MKI67, TOP2A, BIRC5, AURKB, CDK1, PLK1, RRM2, CCNB2, CCNA2, FOXM1) are hallmarks of TA cells, which undergo multiple rounds of division to generate the vast number of differentiated cells needed for the intestinal epithelium. While ISCs are also proliferative, TA cells are typically the most rapidly and extensively dividing population in the crypt. The absence of specific ISC markers in the *highly ranked* list further supports TA cells as the primary component. ### 6. Provide a Concise Summary of Your Analysis: This single-cell cluster from human large intestine tissue exhibits an exceptionally strong and comprehensive expression profile of genes critical for cell cycle progression, DNA replication, and mitosis. Key markers such as MKI67, UBE2C, CENPA, AURKB, BIRC5, TOP2A, FOXM1, CDK1, PLK1, RRM2, CCNB2, and CCNA2 are all highly ranked, indicating a population undergoing rapid and active cell division. There is a notable absence of specific lineage markers for differentiated intestinal cells or immune cells. Cross-referencing with scRNA-seq databases confirms this signature as characteristic of proliferating cells. In the context of the large intestine, this profile is most consistent with **Transit-Amplifying (TA) Cells**, which are highly proliferative progenitor cells responsible for expanding the epithelial lineage from intestinal stem cells. Intestinal Stem Cells (ISCs) are also proliferative but typically show a more nuanced expression profile, and their specific markers are not prominent here. Proliferating enterocyte progenitors represent a more specific commitment within the TA cell pool. Therefore, the most probable annotation for this cluster is **Proliferating Transit-Amplifying (TA) Cells**. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Proliferating Epithelial Cells"", ""sub_cell_types"": [""Transit-Amplifying (TA) Cells"", ""Intestinal Stem Cells (ISCs)"", ""Proliferating Enterocyte Progenitors""], ""possible_mixed_cell_types"": [] } ```"
